• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Bright.md Integrates with GOeVisit, Enters Canadian Market with Virtual Care Platform

by Fred Pennic 07/13/2018 Leave a Comment

Bright.md Lands $8M for Virtual Physician Assistant, Partners with Adventist Health System

This week, Bright.md announced a new and unique customer deployment with Vancouver-based MyCare MedTech, marking its initial expansion into the global marketplace. Until now, the company’s SmartExam platform has been implemented exclusively by traditional brick and mortar healthcare systems like Providence Health & Services, Presbyterian Health Systems and Rush University. However MyCare MedTech tapped Bright.md to enhance its own existing virtual platform, dubbed GOeVisit.

SmartExam enables users to connect with medical practitioners via any smart device to be treated for 400+ minor illnesses and injuries, leveraging AI to conduct clinical interviews and identify low acuity common conditions more efficiently. In fact, most virtual visits can be conducted in two minutes or less.

“The decision to move to this platform was an easy one; it is a superior service that allows us to continue to offer Canadians a unique way to gain access to medical care.” said Liz Bryant, Chief Operating Officer at GOeVisit. “GOeVisit SmartExam is a user-friendly service that has the ability to keep pace with and integrate new and improved technologies in the coming years. We are confident it will outperform all existing virtual healthcare platforms in the market today.”

SmartExam’s artificial intelligence capabilities act as a virtual physician’s assistant, dynamically conducting a clinical interview and using the patients’ answers to gather relevant information to support medical providers in the delivery of virtual care.

 

It provides Canadians with quality care that is private, secure, fast, affordable and convenient. Accessible from anywhere and any device, SmartExam is fully-automated, meaning prescriptions are sent to a pharmacy of choice and the patient summary is sent directly to the patient via a secure link.

 

“With GOevisit SmartExam, we wanted to offer virtual care that provides a high-quality experience for both the patient and the clinician, and allows for continuous improvement,” said Dr. Raj Attariwala, Medical Director of AIM Medical Imaging and Medical Director of GOeVisit. “Medical technology doesn’t stand still, and neither can we.”

Canadians have been receiving care via GOeVisit SmartExam since the beginning of July, joining the millions of healthcare consumers already experiencing the benefits of SmartExam from leading healthcare systems around the United States.

Tagged With: Bright.md, Virtual Care, Virtual Care Platform

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |